Andrea DiMartini

ORCID: 0000-0003-4883-121X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alcohol Consumption and Health Effects
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Neurological Complications and Syndromes
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Electrolyte and hormonal disorders
  • Glycosylation and Glycoproteins Research
  • Bipolar Disorder and Treatment
  • Polyomavirus and related diseases
  • Epilepsy research and treatment
  • Organ Donation and Transplantation
  • Diet, Metabolism, and Disease
  • Nutrition and Health in Aging
  • Pregnancy and Medication Impact
  • Metabolism and Genetic Disorders
  • Palliative Care and End-of-Life Issues
  • Diet and metabolism studies
  • Behavioral Health and Interventions
  • Alcoholism and Thiamine Deficiency
  • Ethics and Legal Issues in Pediatric Healthcare
  • Patient Dignity and Privacy
  • Glycogen Storage Diseases and Myoclonus
  • Substance Abuse Treatment and Outcomes
  • Ethics in medical practice

University of Pittsburgh
2001-2025

Southern California Clinical and Translational Science Institute
2023

Instituto de Salud Carlos III
2016

University of Pittsburgh Medical Center
2000-2015

H.C. Starck (Germany)
2012

UPMC Montefiore
2010

Georgetown University
2006

Georgetown University Medical Center
2006

Hanil General Hospital
2006

University of Oklahoma Health Sciences Center
2000

Alcoholic liver disease has emerged as a leading indication for hepatic transplantation, although it is controversial use of resources. We aimed to examine all aspects transplantation associated with alcohol abuse.Retrospective cohort analysis 123 alcoholic patients median 7 years follow-up at one center.In addition alcohol, 43 (35%) had another possible factor contributing cirrhosis. Actuarial patient and graft survival rates were, respectively, 84% 81% (1 year); 72% 66% (5 years); 63% 59%...

10.1097/00007890-200108270-00010 article EN Transplantation 2001-08-01

Background: Carbohydrate deficient transferrin (CDT), a biochemical marker of chronic alcohol consumption, is used by researchers and clinicians alike in variety populations. Levels CDT may be affected certain types medical illnesses conditions. Thus the interpretation results need to carefully examined these Because synthesized, glycosylated, secreted liver, use values patients with liver disease has been an area focused interest. Methods: We evaluated 79 abstaining end‐stage disease. These...

10.1111/j.1530-0277.2001.tb02182.x article EN Alcoholism Clinical and Experimental Research 2001-12-01

Context-Little is known about patients' contribution to health outcomes after liver transplantation.Yet, in other transplant recipients, nonadherent behavior directly related the leading causes of morbidity and mortality recipients.Objective-To examine patient environmental factors relation all aspects adherence posttransplantation regimen first 6 months transplantation.Design-A descriptive analysis individual at transplantation.Participants, Setting-One hundred fifty-two adult recipients...

10.7182/prtr.20.1.c903845857104k83 article EN Progress in Transplantation 2010-03-01

Calcineurin-inhibiting immunosuppressive medications are the mainstay of posttransplant immunosuppression. Although these highly beneficial drugs critical for survival, significant numbers transplant recipients experience side effects, some requiring a switch to different regimen. Neurotoxicity is one most debilitating effects because its impact on mental status and cognition. As our center uses tacrolimus as initial immunosuppressant all liver (LTX) recipients, we were interested in those...

10.1002/lt.21427 article EN Liver Transplantation 2008-01-01

Posttransplant lymphoproliferative disorder (PTLD) is a well-established complication of immunosuppression. The involvement the gastrointestinal (GI) tract occurs in 25% all cases PTLD. Fortunately, surgical intervention seldom required. We report our experience treatment complicated GI-PTLD after liver transplantation (LTx).A retrospective analysis 5677 adult patients who underwent LTx between 1983 and 2009 was conducted.Thirty-six presented with GI-PTLD. Sixteen complications associated...

10.1097/tp.0b013e3182584854 article EN Transplantation 2012-07-20

Lung transplant candidates face numerous health-related stressors. Although previous work has described the range of coping strategies may use, whether those are related to quality life in physical functioning, emotional, and social domains rarely been examined.Adult lung (N = 128) participated semistructured interviews that included questions regarding global domain-specific a multidimensional assessment with problems. Demographic characteristics, health status, other psychosocial variables...

10.7182/prtr.13.3.gh24822330j26215 article EN Progress in Transplantation 2003-09-01

At our center from August 1989 to December 1992, 834 adults underwent orthotopic liver transplantation (OLT) using tacrolimus as the primary immunosuppressive agent. A total of 183 (22%) had alcohol-related disease. Patients with alcoholic cirrhosis a better though not statistically significant 5-year survival rate compared all other patients. We were interested in specific predictors survival, particularly for cirrhotics who gravely ill at point transplantation.For 78 patients disease...

10.1097/00007890-199808150-00004 article EN Transplantation 1998-08-01

Background: Methods to improve assessment, selection, and monitoring of patients with alcoholic cirrhosis who pursue liver transplantation are sought continuously. We chose investigate the use High‐Risk Alcohol Relapse (HRAR) scale in our transplant population hope that it would ability identify follow at highest risk for alcohol relapse. Methods: Detailed histories 207 evaluated were collected graded severity by using HRAR. The HRAR provides information on duration (a measure chronicity),...

10.1111/j.1530-0277.2000.tb02083.x article EN Alcoholism Clinical and Experimental Research 2000-08-01

Transferrin, an iron transport protein found in serum and cerebrospinal fluid, is known to be microheterogeneous with respect its carbohydrate sialic acid content. The forms of transferrin deficient and/or carbohydrate, termed carbohydrate-deficient (CDT), have been clinical interest for almost two decades as a result the initial finding that elevated CDT concentrations are associated chronic, excessive alcohol abuse. We demonstrate utility capillary electrophoresis examining sialoform...

10.1002/1522-2683(20000701)21:12<2376::aid-elps2376>3.0.co;2-p article EN Electrophoresis 2000-07-01

ABSTRACT Objectives Early alcohol use identification can prevent morbidly/mortality for alcohol-associated liver disease (ALD). Innovative wearable biosensors (biosensors) that identify through perspiration are an emerging technology with potential application Patients ALD. Our primary aim was to determine biosensor acceptability and feasibility We describe participant acceptance challenges using in a pilot study of Design Participants had recent diagnosis or hospitalization decompensated...

10.1097/psy.0000000000001203 article EN Psychosomatic Medicine 2023-04-17

CONTEXT-Patient characteristics are important in the liver transplant (LTX) population because of proven associations between individual and environmental factors, treatment adherence, health outcomes general medical other (txp) populations. OBJECTIVE-The objective this report is to determine generalizability sample LTX populations establish reliability measures used assess resources.DESIGN-This a cross sectional analysis baseline data longitudinal study adherence outcomes.PARTICIPANTS,...

10.7182/prtr.20.1.v4247m0534172188 article EN Progress in Transplantation 2010-03-01

LaPUMA, J.; STOCKING, C. B. M. D.; SILVERSTEIN, ; DIMARTINI, A.; SIEGLER, Author Information

10.1097/00132586-198904000-00043 article EN Survey of Anesthesiology 1989-04-01

A. Liver transplantation (LT) patients with alcoholic liver disease (ALD) often have the comorbid psychiatric disorder of alcohol dependence (AD). 1. Not all AD will develop ALD. 2. Most, but not patients, ALD be AD. 3. Approximately 75-80% LT B. Diagnostic criteria use disorders. Alcohol abuse. a. Clinically important impairment or distress repeatedly in one more following items a 12-month period. i. Failure to fulfill major obligations (e.g., absences/suspension from work, neglecting...

10.1002/lt.21342 article EN Liver Transplantation 2007-01-01

10.1016/0163-8343(92)90005-u article EN General Hospital Psychiatry 1992-11-01

Abstract Introduction We aimed to determine acceptability and feasibility of innovative wearable alcohol biosensor monitors (ABM) for patients with alcohol‐related liver disease (ALD) their clinicians. Methods Patients clinicians at a tertiary care centre participated in qualitative interviews on usability, acceptability, feasibility, efficiency/effectiveness, impact device behaviour/clinical practice preferences/barriers. Interviews were audiotaped, transcribed coded using constant...

10.1111/dar.13978 article EN cc-by-nc-nd Drug and Alcohol Review 2024-12-09

Alcohol-related liver disease has become one of the most common indications for transplantation. Over past decade, our clinical experience with patients transplanted alcohol-related coupled multidecade studies from general alcoholic population have given direction to research questions this unique patient population. Although concerns over posttransplant alcohol relapse are foremost, few return pathologic drinking that results in morbidity or mortality. Beginning attempts at modeling...

10.1097/00075200-199906000-00016 article EN Current Opinion in Organ Transplantation 1999-06-01

Background: Carbohydrate deficient transferrin (CDT), a biochemical marker of chronic alcohol consumption, is used by researchers and clinicians alike in variety populations. Levels CDT may be affected certain types medical illnesses conditions. Thus the interpretation results need to carefully examined these Because synthesized, glycosylated, secreted liver, use values patients with liver disease has been an area focused interest. Methods: We evaluated 79 abstaining end-stage disease. These...

10.1097/00000374-200112000-00006 article EN Alcoholism Clinical and Experimental Research 2001-12-01
Coming Soon ...